OPTIBIOTIX HEALTH

optibiotix-health-logo

OptiBiotix develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease. The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diab... etes. OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreenยฎ and OptiBioticยฎ platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.

#SimilarOrganizations #People #Website #More

OPTIBIOTIX HEALTH

Social Links:

Industry:
Biotechnology Health Care Life Science

Founded:
2006-07-19

Address:
Heslington, York, United Kingdom

Country:
United Kingdom

Website Url:
http://www.optibiotix.com

Total Employee:
1+

Status:
Active

Contact:
020 7933 8780

Email Addresses:
[email protected]

Total Funding:
1.5 M GBP

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Mobile Non Scaleable Content


Similar Organizations

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Current Employees Featured

stephen-o-hara_image

Stephen O&s; Hara
Stephen O' Hara Founder and Chief Executive @ Optibiotix Health
Founder and Chief Executive

not_available_image

Mark Collingbourne
Mark Collingbourne CFO @ Optibiotix Health
CFO

Founder


stephen-o-hara_image

Stephen O' Hara

Stock Details


Company's stock symbol is LSE:OPTI

Official Site Inspections

http://www.optibiotix.com Semrush global rank: 4.29 M Semrush visits lastest month: 2.69 K

  • Host name: cloud2304.liveboxserver.uk
  • IP address: 149.255.58.79
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Optibiotix Health"

Corporate - Optibiotix

Stephen founded OptiBiotix in May 2012, SkinBiotix (subsequently SkinBiotherapeutics plc) in 2015, and ProBiotix health Ltd in 2018, to commercialise opportunities in the immature but โ€ฆSee details»

Home - Optibiotix

OptiBiotix Health Plc. is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing technologies that modulate the human microbiome โ€“ โ€ฆSee details»

Company Information | Better Science, better Health - OptiBiotix โ€ฆ

OptiBiotix Health Plc is a company incorporated in England and Wales under the Companies Act 2006 with company number 5880755. The Company's main country of operations is the โ€ฆSee details»

OptiBiotix Health Plc - LinkedIn

OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. OptiBiotix Health Plc | โ€ฆSee details»

OptiBiotix Health Plc - AnnualReports.com

Optibiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops โ€ฆSee details»

Optibiotix Health - Crunchbase Company Profile & Funding

OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline โ€ฆSee details»

Corporate Governance | Better Science, better Health | OptiBiotix ...

OptiBiotix Health Plc is committed to the highest standards of corporate social responsibility in its activities, as outlined in more detail in the annual report and accounts. Feedback from โ€ฆSee details»

AIM Rule 26 | Better Science, better Health - OptiBiotix Health plc

Feb 16, 2024 OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development โ€ฆSee details»

OptiBiotix Health Company Description - Stock Analysis

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators in the United Kingdom, the United States, China, and internationally. โ€ฆSee details»

Optibiotix Health Company Profile - Office Locations ... - Craft

Oct 29, 2024 OptiBiotix Health PLC, formerly Ducat Ventures PLC, is a United Kingdom-based life sciences company developing compounds to tackle obesity, high cholesterol and diabetes. โ€ฆSee details»

History | ProBiotix Health Plc

Mar 31, 2022 In support of this strategy, OptiBiotix established ProBiotix in 2018, recognising that its probiotics business had achieved sufficient scientific and commercial maturity, with โ€ฆSee details»

Optibiotix Health - Funding, Financials, Valuation & Investors

Optibiotix Health discovers and develops microbial strains, compounds and formulations, which modulate the human microbiome. Search Crunchbase. ... How much funding has this โ€ฆSee details»

OptiBiotix - VentureRadar

OptiBiotix discovers and develops microbial strains, compounds and formulations, which modulate the human microbiome. Our R&D approach uses pharma grade platforms targeted on the food โ€ฆSee details»

Science & Technology - Optibiotix

The Human Microbiome / Microbiome Market Potential / The Science / Technology Platforms / Publications The Human Microbiome The human digestive tract contains a complex and โ€ฆSee details»

OptiBiotix grows microbiome presence after floating subsidiary

Jun 10, 2022 โ€œWith the global probiotics market estimated to be valued at $61.1 billion [£48.8bn] in 2021 and projected to reach $91.1 billion [£72.2bn] by 2026, OptiBiotix is well placed to take โ€ฆSee details»

Annual & Interim Reports - OptiBiotix Health plc

ProBiotix Health anticipating "big commercial opportunities" during 2023 Group CEO Stephen Oโ€™Hara and CEO Steen Anderson | 04 January 2023 www.proactiveinvestors.co.ukSee details»

Microbiome, Probiotics and Heart Health - Optibiotix

May 4, 2018 Probiotics have long been used in functional foods and supplements to restore the gutโ€™s ideal microbial balance and address gastrointestinal issues. Advances in our โ€ฆSee details»

Latest Results | Better Science, better Health - OptiBiotix Health plc

Sep 27, 2024 OptiBiotix Health India. OptiBiotix Health India (OHI) was formed in November 2021 as a mid- to long-term strategic investment in the worldโ€™s most populous nation of 1.4bn โ€ฆSee details»

Products - Optibiotix

OptiBiotix to launch its finished product WellBiome® for the US market at SupplySide West. 13th September 2023 | News. ProBiotix Health expands heart health range with CholBiome®VH. โ€ฆSee details»

News Archives - Optibiotix

OptiBiotix to launch new WellBiome® solution for wellbeing and healthy ageing consumer market at Vitafoods Europe 2023. 27th February 2023 | News. OptiBiotix launches GoFigure® in โ€ฆSee details»

linkstock.net © 2022. All rights reserved